Publication from the Thomas J. Long School of Pharmacy at University of the Pacific.
Printing is not supported at the primary Gallery Thumbnail page. Please first navigate to a specific Image before printing.
-
Pacific RxTracts - February 2025
Pacific RxTracts
Articles:
- Revolutionizing Hypertension Screening: AI-Enhanced ECG as a Proactive Healthcare Tool
- Breaking News:
- New Indication for Zepbound
- FDA Approves Injectable Nivolumab: A New Era for Opdivo in Cancer Care
- Stromal Stem Cells for Steroid-Refractory Acute Graft-vs-Host Disease
- Cardiology:
- Beta Blocker vs. Verapamil Therapy for Hypertrophic Cardiomyopathy
- General News:
- Prolactin-Increasing Antipsychotics Increase the Odds of Breast Cancer
- Hope for a Cytomegalovirus Vaccine: mRNA-1647
- Targeting IL-13: Innovations in the Treatment of Atopic Dermatitis
- Beyond Opioids: Multimodal Pain Management in Colorectal Surgery
- A Nanomaterial Dosage Form for Mupirocin
- Guselkumab, a potential drug for Ulcerative colitis
- Neuropsychiatry:
- Dextromethorphan for Depression: More For Just a Cold
- Breakthrough in PTSD Treatment: Brexpiprazole + Sertraline Combination Outperforms SSRI Monotherapy
- A New Way to Treat Obsessive Compulsive and Related Disorders
- Sovateltide: A Novel Drug for Acute Cerebral Ischemic Stroke Treatment
-
Pacific RxTracts - March 2025
Pacific RxTracts
Articles
- Naloxone Extended-Release System Discovered at the University of the Pacific
- FDA Approval for Unresectable/ Metastatic Breast Cancer
- Journavx (Suzetrigine): A New Era in Pain Management
- New Treatment Approved for Congenital Adrenal Hyperplasia
- Optimal DAPT Strategy? A Promising Approach for Post-PCI Care
- Benefit of SGLT2 Inhibitors in Preventing Contrast-Induced Kidney Injury
- Dark Chocolate and Type 2 Diabetes: A Sweet Connection?
- Confirming Palbociclib’s Safety in Liver Impaired Patients
- Aztreonam-avibactam, a Promising Therapeutic for Gram-Negative Bacterial Infections
- The Future is Now: LBP-EC01, a Genetically Enhanced Bacteriophage for UTIs
- The Safety and Efficacy Profiles of Short-Term Duration Oral Regimens for Rifampin-Resistant TB
- A New Boxed Warning for Glatiramer Acetate
- Clozapine: From Last Resort to Second-Line Therapy?
- Esketamine (Spravato CIII) Receives FDA Approval as First Monotherapy Treatment for Treatment-Resistant Depression
- Evaluation of the Impacts of Cannabis Use on Brain Function
-
Pacific RxTracts - December 2024
Pacific RxTracts
Articles
- Attruby: A Promising Treatment for Transthyretin Amyloid Cardiomyopathy
- Triple Threat: GMRx2, An Emerging Low-Dose Triple Pill For Hypertension
- New Treatment for Hemophilia A or B
- Breaking the Placebo Barrier: FDA Review Challenges Effectiveness of Popular Decongestant
- Exploring Bempedoic Acid: Potential Benefits for Statin-Intolerant Patients and Liver Health
- The Flu Vaccine: Meeting You Where You Are
- Unique Application of Statins for Radiotherapy-Induced Cardiotoxicity
- One Shot, Two Solutions: How Semaglutide Combats Obesity and Knee Osteoarthritis
-
Pacific RxTracts - November 2024
Pacific RxTracts
Articles:
- Semaglutide: Hope for Alzheimer's Prevention
- A New Potential Indication for Tirzepatide
- New Drug Target for Treating Schizophrenia
- The Prevent Calculator: Does America Have A Statin Problem?
- Weighing the Risks vs. Benefits of Liraglutide for Children
- CD19-CAR T-Cell Therapy: Revolutionizing Autoimmune Disease Treatment
- Conceived with Technology, Born with Risks: ART Babies and Heart Defects
- Machine Learning and Neural Networks: The Future of Clinical Pharmacy?. .
-
Pacific RxTracts - October 2024
Pacific RxTracts
Articles
- First Nasal Spray for Anaphylaxis Approved
- Statins: The Unexpected Therapeutic Benefits You Didn’t Know About
- Is COVID Driving Us Mad? The Mental Toll on the Unvaccinated vs. Vaccinated
- Acetaminophen’s Effects on Positive Empathy
- Semaglutide: More Than Meets The Eye
- RSV: Complications and New Therapies
- Contribution of Calcium Channel Blockers and Selective Serotonin Reuptake Inhibitors to the Risk of Fractures
